Publication

This paper outlines policies on global health issues for the next US administration. The author argues that the next president must develop a coherent set of activities in support of global health goals, with the chosen priorities reflected in development assistance, the allocation of resources for biomedical research and tax credits for pharmaceutical companies and other players.